INVESTING IN MORE THAN A SIDE DISH
Canada-based Dainty Foods will soon establish its first U.S. operations just outside of Cincinnati, Ohio. Last week, the private-label rice products manufacturer shared news of an of a potential $150 million investment into Batavia Township to support the construction of the new 250,000-sq.-ft. plant. “This investment marks a transformative milestone in Dainty’s growth strategy,” said Les Aliments Dainty Foods Inc. CEO James Maitland. “Establishing Dainty USA LLC strengthens our presence in the U.S. market, increases production capacity with world-class automation, and brings innovative, convenient meal solutions closer to American consumers. The site was chosen for its Midwest supply chain strength, workforce, infrastructure and business-friendly environment.” Of the investment, $85 million will be used to support the facility’s construction, while an additional $65 million could be used to expand future production capacity. Dainty Foods plans to produce microwave rice pouches and bowls for North American consumers in response to growing market demands. Operations are slated to begin by early 2027.
Photo courtesy of Novo Nordisk
IRELAND SWALLOWS NEW LIFE SCIENCES INVESTMENT
Novo Nordisk plans to deliver a $506 million expansion to its manufacturing site in the central Ireland town of Athlone. The pharmaceutical giant is looking to make room for increased GLP-1 oral treatment production at its Monksland tabletting facility. The expansion will bring the massive site to cover 45 acres, cementing the company’s commitment to Ireland’s life sciences industry. In the company’s official press release, it noted this investment will allow Ireland to serve as a critical hub for supporting markets outside of the United States. Construction has already begun with full buildout expected in 2028. “With the investment in the Athlone facility, Novo Nordisk is expanding its production capacities for oral products, which will strengthen our ability to meet both current and future demand outside the U.S.,” said Novo Nordisk EVP of CMC & Product Supply Kasper Bødker Mejlvang. “This investment, a historic milestone for Novo Nordisk in Ireland, marks our continued commitment to Ireland and our highly skilled employees in Athlone while allowing us to make a difference for millions of people living with serious chronic diseases.”
A SUSTAINABLE EXPANSION
Shintech Louisiana, a subsidiary of leading U.S. polyvinyl chloride (PVC) producer Shintech Inc., has announced a multibillion-dollar expansion of its Iberville Parish manufacturing plant. The expansion will allow the company to integrate advanced manufacturing technology to aid in lowering emissions, while boosting PVC production at the Plaquemine site. Shintech Louisiana’s $3.4 billion investment supports the construction of a new ethylene unit and an additional chlor-alkali and vinyl chloride monomer unit. “This investment aligns with Shintech’s strategy to ensure reliable and cost-effective supply of key feedstocks for our business,” said Shintech Inc. President Yasuhiko Saitoh. The company has operated in the region for over 21 years, becoming its largest taxpayer. The state offered Shintech a $23.5 million performance-based grant and workforce development support through LED FastStart, in addition to expected participation in Louisiana’s Industrial Tax Exemption and Quality Jobs programs. Construction will move along in phases, with the initial phase expected to be complete by 2030, creating 163 direct new jobs.
Reports compiled and written by Alexis Elmore
